Schrödinger, Inc. is a computational drug discovery platform company that develops proprietary software and provides services to support pharmaceutical and biotechnology clients in accelerating their drug discovery and development processes. The company's platform leverages computational chemistry, machine learning, and physics-based simulations to help clients identify drug candidates, optimize molecular structures, and evaluate compound properties more efficiently than traditional methods, serving biopharmaceutical companies and research institutions through collaboration agreements, licensing arrangements, and research partnerships. The company generates revenue from drug discovery services, license agreements, and research collaborations with pharmaceutical partners, while also developing proprietary internal product candidates that may generate future revenues upon regulatory approval and commercialization.